Fukazawa et al., 2016 - Google Patents
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinomaFukazawa et al., 2016
View HTML- Document ID
- 3415395532322470004
- Author
- Fukazawa T
- Guo M
- Ishida N
- Yamatsuji T
- Takaoka M
- Yokota E
- Haisa M
- Miyake N
- Ikeda T
- Okui T
- Takigawa N
- Maeda Y
- Naomoto Y
- Publication year
- Publication venue
- Scientific reports
External Links
Snippet
Since the SOX2 amplification was identified in lung squamous cell carcinoma (lung SCC), SOX2 transcriptional downstream targets have been actively investigated; however, such targets are often cell line specific. Here, in order to identify highly consensus SOX2 …
- 102000000578 Cyclin-Dependent Kinase Inhibitor p21 0 title abstract description 73
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fukazawa et al. | SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma | |
Sun et al. | circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression | |
Gandhi et al. | The lncRNA lincNMR regulates nucleotide metabolism via a YBX1-RRM2 axis in cancer | |
Zhao et al. | Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer | |
Xu et al. | Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer | |
Wang et al. | LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci | |
Bao et al. | MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway | |
Lin et al. | The genomic landscape of nasopharyngeal carcinoma | |
Enfield et al. | Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma | |
Parasramka et al. | BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma | |
Zuber et al. | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia | |
Pawłowski et al. | Loss of PBRM1 expression is associated with renal cell carcinoma progression | |
Chatterjee et al. | Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer | |
Huang et al. | SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis | |
Sun et al. | Oncogenic features of PHF8 histone demethylase in esophageal squamous cell carcinoma | |
Gruosso et al. | MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas | |
Bao et al. | EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy | |
Deng et al. | RETRACTED ARTICLE: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma | |
Das et al. | miRNA-302s may act as oncogenes in human testicular germ cell tumours | |
Liu et al. | GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer | |
Lin et al. | Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer | |
Sun et al. | Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma | |
Chen et al. | LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression | |
Zhou et al. | Long noncoding RNA MALAT1 sponging miR-26a-5p to modulate Smad1 contributes to colorectal cancer progression by regulating autophagy | |
Zhou et al. | Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies |